Please assess the completion status of the following clinical trial:

Trial Title: Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients with primary open-glaucoma (POAG), primary angle-closure glaucoma (PACG), pseudoexfoliation, pigmentary, traumatic, uveitic or neovascular glaucoma~Exclusion Criteria:~1. Age ≤ 18 years old.~2. Any type of glaucoma other than those listed in the inclusion criteria.~3. Less than 3 months of other ocular surgery.~4. Active thyroid-related immune orbitopathy, carotid-cavernous fistula, Sturge Weber syndrome, orbital tumors or orbital congestive disease.~5. Patients with connective tissue disorder.~6. Patients with congenital or developmental glaucoma.~7. Patients with severe dry eye syndrome.~8. Patients with any surgical procedure involving revision, removal, or change of the existing glaucoma tube shunt.~9. Patients undergoing any surgical concomitant surgical procedure involving the posterior segment.~10. Patients with active scleritis, history of ocular trauma including chemical burn, chronic ocular inflammatory disease, or ocular surface disease.~11. Patients with any prior history of allergy to the active compound.~12. Pregnancy or breast-feeding.~13. Patients enrolled in other prospective clinical trials.~14. Patients that plan to use contact lens after surgery.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- KeraSys Tissue Patch Graft (Type: ACTIVE_COMPARATOR): 20 patients needing a Molteno 3 glaucoma drainage shunt implant will receive the KeraSys patch graft
- Tutoplast tissue patch graft (Type: ACTIVE_COMPARATOR): 20 patients need Molteno 3 glaucoma drainage surgery will receive tutoplast patch graft

Based on this trial design, predict the completion outcome and termination type (if applicable).